Number of the records: 1
integrín alfa4
SYS d039441 LBL 00000nz--a2200000o--4500 005 20250606213908.9 008 020703|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D12.776.543.750.705.408.100.450 066 $a 01 $c 03 150 $a integrín alfa4 $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a Antigens, CD49d $2 eng 450 $w v $a CD49d Antigens $2 eng 450 $w v $a antigény CD49d $2 slo 550 $7 sllk_us_auth*d000069442 $Y Natalizumab $w p $a natalizumab 550 $7 sllk_us_auth*d000069442 $Y Natalizumab $w b $a natalizumab 665 $a 2003 (1994) $2 eng 665 $a Antigens, CD (1994-2002) $2 eng 680 9-
$i An integrin alpha subunit that is unique in that it does not contain an I-domain, and its proteolytic cleavage site is near the middle of the extracellular portion of the polypeptide rather than close to the membrane, as in other integrin alpha subunits. $2 eng 750 -2
$a Integrin alpha4 $2 eng 980 $x M
Number of the records: 1